These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1930334)

  • 1. Effect of medication on synovial fluid leukocyte differentials in patients with rheumatoid arthritis.
    Bahremand M; Schumacher HR
    Arthritis Rheum; 1991 Sep; 34(9):1173-6. PubMed ID: 1930334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1989 Jun; 31(795):61-4. PubMed ID: 2567489
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction of leukocyte and interleukin-1 beta concentrations in the synovial fluid of rheumatoid arthritis patients treated with methotrexate.
    Thomas R; Carroll GJ
    Arthritis Rheum; 1993 Sep; 36(9):1244-52. PubMed ID: 8216418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis.
    Clegg DO; Ward JR
    Nurse Pract; 1987 Mar; 12(3):44, 49-52. PubMed ID: 2882451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo effects of antirheumatic drugs on neutral collagenolytic proteases in human rheumatoid arthritis cartilage and synovium.
    Martel-Pelletier J; Cloutier JM; Pelletier JP
    J Rheumatol; 1988 Aug; 15(8):1198-204. PubMed ID: 3054093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid arthritis: a pharmacologic overview.
    Pinals RS
    Am Fam Physician; 1988 Mar; 37(3):145-52. PubMed ID: 2894754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs.
    Pincus T; Callahan LF
    Agents Actions Suppl; 1993; 44():67-75. PubMed ID: 8103964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug therapy in the rheumatic diseases.
    Reardon EV; Clough JD
    Compr Ther; 1992 Nov; 18(11):22-5. PubMed ID: 1478055
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs.
    Taha AS; Capell HA; Sturrock RD; Russell RI
    Am J Gastroenterol; 1991 Nov; 86(11):1588-91. PubMed ID: 1683150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis.
    van Jaarsveld CH; Jahangier ZN; Jacobs JW; Blaauw AA; van Albada-Kuipers GA; ter Borg EJ; Brus HL; Schenk Y; van Der Veen MJ; Bijlsma JW
    Rheumatology (Oxford); 2000 Dec; 39(12):1374-82. PubMed ID: 11136881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominance of synovial fluid lymphocytes in early rheumatoid arthritis.
    Gatter RA; Richmond JD
    J Rheumatol; 1975 Sep; 2(3):340-5. PubMed ID: 171408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatment of arthritis. Update on conventional and less conventional methods.
    Spencer-Green G
    Postgrad Med; 1993 May; 93(7):129-40. PubMed ID: 8493195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid peroxidation and malondialdehyde in the synovial fluid and plasma of patients with rheumatoid arthritis.
    Wade CR; Jackson PG; Highton J; van Rij AM
    Clin Chim Acta; 1987 May; 164(3):245-50. PubMed ID: 3594915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydial infection preceding the development of rheumatoid arthritis: a brief report.
    Jolly M; Curran JJ
    Clin Rheumatol; 2004 Oct; 23(5):453-5. PubMed ID: 15459816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid arthritis. Practical use of medications.
    Furst DE
    Postgrad Med; 1990 Feb; 87(3):79-92. PubMed ID: 2406713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
    Kovarsky J
    Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276
    [No Abstract]   [Full Text] [Related]  

  • 17. Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis.
    Raza K; Scheel-Toellner D; Lee CY; Pilling D; Curnow SJ; Falciani F; Trevino V; Kumar K; Assi LK; Lord JM; Gordon C; Buckley CD; Salmon M
    Arthritis Res Ther; 2006; 8(4):R120. PubMed ID: 16859518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylprednisolone infusion therapy in rheumatoid arthritis patients. The effect on synovial fluid lymphocyte subsets and inflammatory indices.
    Bertouch JV; Roberts-Thomson PJ; Smith MD; Woodruff TG; Brooks PM; Bradley J
    Arthritis Rheum; 1986 Jan; 29(1):32-8. PubMed ID: 3947416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulatory drugs in the treatment of juvenile rheumatoid arthritis (JRA).
    Høyeraal HM
    Scand J Rheumatol Suppl; 1988; 76():305-10. PubMed ID: 3075085
    [No Abstract]   [Full Text] [Related]  

  • 20. Histologic changes in rheumatoid synovitis induced by naproxen and methotrexate.
    Balsa A; Gamallo C; Martín-Mola E; Gijón-Baños J
    J Rheumatol; 1993 Sep; 20(9):1472-7. PubMed ID: 8164201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.